Biovica International AB (publ) (STO:BIOVIC.B)

Sweden · Delayed Price · Currency is SEK

0.5280

+0.0380 (7.76%)

Jul 24, 2026, 5:29 PM CET

Revenue by Segment

Financials in millions SEK. Fiscal year is May - April.

Millions SEK. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017
Biotechnology	13.49M	8.65M	7.30M	5.21M	5.10M
Biotechnology Growth	55.93%	18.55%	39.99%	2.22%	-31.84%
Total	13.49M	8.65M	7.30M	5.21M	5.10M
Total Growth	55.93%	18.55%	39.99%	2.22%	-31.84%

Revenue by Geography

Financials in millions SEK. Fiscal year is May - April.

Millions SEK. Fiscal year is May - Apr.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025	Apr '24 Apr 30, 2024	Apr '23 Apr 30, 2023	Apr '22 Apr 30, 2022	Apr '21 Apr 30, 2021	Apr '20 Apr 30, 2020	Apr '19 Apr 30, 2019	Apr '18 Apr 30, 2018	Apr '17 Apr 30, 2017
EU Excl. Sweden	1.19M	531.00K	1.37M	125.00K	102.00K
EU Excl. Sweden Growth	123.35%	-61.21%	995.20%	22.55%	-80.79%
USA	11.69M	7.55M	5.58M	3.26M	1.94M
USA Growth	54.75%	35.27%	71.36%	67.68%	55.81%
Asia	507.00K	536.00K	-	-	-
Asia Growth	-5.41%	-	-	-	-
Sweden	-	-	41.00K	-	-
Rest of The World	-	-	297.00K	-	-
Total	13.38M	8.62M	7.29M	3.38M	2.05M
Total Growth	55.24%	18.23%	115.49%	65.43%	-1.54%